Thenalidine tartrate | CAS#2784-55-6 | H1-receptor antagonist

MedKoo Cat#: 464232 | Name: Thenalidine tartrate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Thenalidine is an antihistamine with anticholinergic properties used as an antipruritic drug. It was withdrawn from the US, Canadian, and UK markets due to a risk of neutropenia. Thenalidine is an antagonist of the H1-receptor.

Chemical Structure

Thenalidine tartrate

CAS#2784-55-6

Theoretical Analysis

MedKoo Cat#: 464232

Name: Thenalidine tartrate

CAS#: 2784-55-6

Chemical Formula: C21H28N2O6S

Exact Mass: 436.1668

Molecular Weight: 436.52

Elemental Analysis: C, 57.78; H, 6.47; N, 6.42; O, 21.99; S, 7.34

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Thenalidine tartrate; Thenophenopiperidine tartrate;

IUPAC/Chemical Name

1-methyl-N-phenyl-N-(thiophen-2-ylmethyl)piperidin-4-amine (2R,3R)-2,3-dihydroxysuccinate

InChi Key

JNZAGODMPIMPAM-LREBCSMRSA-N

InChi Code

InChI=1S/C17H22N2S.C4H6O6/c1-18-11-9-16(10-12-18)19(14-17-8-5-13-20-17)15-6-3-2-4-7-15;5-1(3(7)8)2(6)4(9)10/h2-8,13,16H,9-12,14H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1

SMILES Code

CN1CCC(N(c2ccccc2)Cc3sccc3)CC1.O[C@@H](C(O)=O)[C@H](C(O)=O)O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

	Solvent	mg/mL	mM	comments
Solubility
	To be determined	0.0	0.00

Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 436.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: ADAMS DA, PERRY S. Agranulocytosis associated with thenalidine (sandostene) tartrate therapy; report of three cases. J Am Med Assoc. 1958 Jul 5;167(10):1207-10. doi: 10.1001/jama.1958.02990270013004. PMID: 13549246. 2: GREGOIRE F, COMEAU M, ROY L. Thenalidine tartrate (sandostene) as an adjuvant in courses of specific desensitization. Can Med Assoc J. 1960 Mar 5;82(10):518-22. PMID: 13851689; PMCID: PMC1937864. 3: STEVENSON J, KENNEDY AC. A fatal case of agranulocytosis due to thenalidine tartrate complicated by acute renal failure and mycelial abscesses of brain. Scott Med J. 1961 Nov;6:522-5. doi: 10.1177/003693306100601104. PMID: 13917095. 4: LIND I, OMAN S. [Agranulocytosis after thenalidine tartrate]. Nord Med. 1961 Jan 12;65:42-4. Swedish. PMID: 13762246.